|[February 07, 2014]
Research and Markets: Bone Fracture - Pipeline Review, H2 2013 Research Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/ztg2gl/bone_fracture)
has announced the addition of the "Bone
Fracture - Pipeline Review, H2 2013" report to their offering.
'Bone Fracture - Pipeline Review, H2 2013', provides an overview of the
indication's therapeutic pipeline. This report provides information on
the therapeutic development for Bone Fracture, complete with latest
updates, and special features on late-stage and discontinued projects.
It also reviews key players involved in the therapeutic development for
- A snapshot of the global therapeutic scenario for Bone Fracture.
- A review of the Bone Fracture products under development by companies
and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of montherapy and
- Coverage of the Bone Fracture pipeline on the basis of route of
administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Bone Fracture Overview
Pipeline Products for Bone Fracture - Overview
Pipeline Products for Bone Fracture - Comparative Analysis
Bone Fracture - Therapeutics under Development by Companies
Bone Fracture - Therapeutics under Investigation by
Bone Fracture - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Bone Fracture - Products under Development by Companies
Bone Fracture - Products under Investigation by Universities/Institutes
Bone Fracture - Companies Involved in Therapeutics Development
Bone Fracture - Therapeutics Assessment
KCB-1B - Drug Profile
Allogeneic Stem Cells - Drug Profile
AZD-2858 - Drug Profile
Bone Regeneration Project - Drug Profile
JVS-200 - Drug Profile
denosumab biosimilar - Drug Profile
Calcitonin Receptor Peptide - Drug Profile
17Beta-HSD2 Inhibitors - Drug Profile
Recombinant BMP-2 Biosimilar - Drug Profile
Nitric Oxide Synthase Antagonist - Drug Profile
Kaken Pharmaceutical Co., Ltd.
Juventas Therapeutics, Inc.
Laboratorios SALVAT S.A.
Bone Therapeutics SA
bioXPRESS Therapeutics SA
For more information visit http://www.researchandmarkets.com/research/ztg2gl/bone_fracture
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To TMCnet.com's Homepage ]